Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial-Reference-Cited by-同舟云学术

Venetoclax plus 3 + 7 daunorubicin and cytarabine chemotherapy as first-line treatment for adults with acute myeloid leukaemia: a multicentre, single-arm, phase 2 trial

Published:2022-06 Issue:6 Volume:9 Page:e415-e424
ISSN:2352-3026
Container-title:The Lancet Haematology
language:en
Short-container-title:The Lancet Haematology

Author:

Wang Huafeng,Mao Liping,Yang Min,Qian Pengxu,Lu Huan,Tong Hongyan,Xie Wanzhuo,Zhou De,Huang Xin,Wang Yungui,Xu Gaixiang,Lu Ying,Wei Juying,Mai Wenyuan,Ye Xiujin,Meng Haitao,Shen Yaojia,Huang Jian,Yu Wenjuan,Sun Jie,Sheng Jianpeng,Yan Xiaoyan,Jin Jie,Zhu Hong-Hu

Publisher

Elsevier BV

Subject

Hematology

Reference26 articles.

1. Cytosine arabinoside (NSC-63878) and daunorubicin (NSC-83142) therapy in acute nonlymphocytic leukemia;Yates;Cancer Chemother Rep,1973

2. Anthracycline dose intensification in acute myeloid leukemia;Fernandez;N Engl J Med,2009

3. Optimization of chemotherapy for younger patients with acute myeloid leukemia: results of the medical research council AML15 trial;Burnett;J Clin Oncol,2013

4. Comparison of 60 or 90 mg/m(2) of daunorubicin in induction therapy for acute myeloid leukemia with intermediate or unfavorable cytogenetics;Devillier;Am J Hematol,2015

5. Prospective randomized comparison of idarubicin and high-dose daunorubicin in induction chemotherapy for newly diagnosed acute myeloid leukemia;Lee;J Clin Oncol,2017

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitochondria and Acute Leukemia: A Clinician’s Perspective;International Journal of Molecular Sciences;2024-09-07

2. Anti-PD-1 combined with hypomethylating agent and CAG regimen bridging to allogeneic hematopoietic stem cell transplantation: a novel strategy for relapsed/refractory acute myeloid leukemia;Frontiers in Immunology;2024-08-16

3. Ven the dose matters: Venetoclax dosing in the frontline treatment of AML;Blood Reviews;2024-08

4. Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial;Hematological Oncology;2024-07

5. Venetoclax therapy and emerging resistance mechanisms in acute myeloid leukaemia;Cell Death & Disease;2024-06-12